BTS MDR-TB Clinical Advice Service
The MDR-TB Clinical Advice Service provides advice and support to clinicians across the UK who encounter MDR-TB. The advice is offered by a multidisciplinary panel of Clinical Service Advisers, with expertise in areas such as respiratory medicine, infectious diseases, microbiology, pharmacy and public health. The advice is provided via a secure online case discussion forum and at monthly MDT meetings which are held via Teams.
If you are a clinician who would like to make use of this service, please register for an account:
BTS MDR-TB Clinical Advice Service
For further information or queries please mdrtb@brit-thoracic.org.uk
Downloads
- BTS MDR-TB Clinical Advice Service Annual Report 2023
- Addendum to BTS MDR-TB Clinical Advice Service Annual Report 2023 (March 2024)
- Quick Start Guide for Clinicians
- Fair Processing Information
- MDR-TB CAS Sheet A Patient Demographics
- MDR-TB CAS Sheet B Clinical Information
- MDR-TB CAS Sheet C Follow up
- BTS MDR-TB Clinical Advice Service Annual Report 2021
- BTS MDR-TB Clinical Advice Service: Drug Toxicity in the UK - Supplemental Report 2021
- BTS MDR-TB Clinical Advice Service Annual Report 2020
- BTS MDR-TB Clinical Advice Service Annual Report - summary 2020
- BTS WInter Meeting 2019 - presentation on the MDR-TB Clinical Advice Service
Links
- BTS MDR-TB Clinical Statement - November 2016
- WHO consolidated guidelines on drug-resistant tuberculosis treatment - December 2022
- WHO consolidated guidelines on drug-resistant tuberculosis treatment - March 2021
- WHO consolidated guidelines on drug-resistant tuberculosis treatment - June 2020
- WHO Rapid Communication on updated guidance for the treatment of drug-resistant tuberculosis - May 2022
- TB Alert